India could potentially lose $6 billion or 0.16 per cent GDP in exports to the US at 10 per cent broad tariffs, with this ...

India is considering cutting tariffs on $23 billion worth of US imports to secure trade relief amid Trump’s new reciprocal ...

The Nifty Pharma index closed on a negative note on Tuesday. Shares of J B Chemicals & Pharmaceuticals Ltd.(up 3.03 per cent) ...

AM(IST)on Tuesday in an upbeat market. Abbott India Ltd.(up 0.74 per cent), Gland Pharma Ltd.(up 0.68 per cent), Biocon ...

President Donald Trump and his administration have been promoting April 2 as a kind of tariffs Super Bowl, during which all ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Eli Lilly (LLY) stock in focus as the company launches its weight loss therapy Mounjaro in India, beating its rival Novo Nordisk (NVO). Read more here.

India’s biggest pharma company said in a press release filed with the stock exchanges in Mumbai on March 10. The deal will bring Unloxcyt (cosibelimab-ipdl), the first and only FDA-approved anti ...

Sun Pharma, India's largest pharmaceutical company ... for each share of common stock they hold, an upfront cash payment of $4.1. The transaction is subject to Checkpoint’s shareholder and ...

The US imports pharmaceutical formulations worth $9 billion from India annually, which is roughly a third of India’s total exports of these items. The highly lucrative nature of US market makes ...